2023 marks the post-pandemic return of research exchanges hosted by the ACR & EULAR to benefit junior academic rheumatologists & rheumatology professionals.
Noelle Rolle, MBBS, Begins New Term as Chair of Collaborative Initiatives Committee
Throughout her medical training, Noelle A. Rolle, MBBS, encountered many patients struggling with both rheumatic disease and issues of health equity and access to care. This drew her to rheumatology and, now, to lead the ACR’s Collaborative Initiatives Committee.
Beyond the Rheumatologist: Interprofessional Alliances Are Crucial to Rheumatic Care
How can we ensure patients are receiving care that addresses all of the ways rheumatic disease affects their life? In this ACR Convergence 2023 session, experts discuss the value of a strong interprofessional care team.
Curbside Consults: Experts Weigh in on Complex Rheumatic Conditions
In this ACR Convergence 2023 session, experts offered guidance on a selection of diagnostic & treatment challenges rheumatologists may encounter.
Duke University Names Dr. Megan Clowse to Lead Rheumatology Division
In October 2023, Megan E.B. Clowse, MD, MPH, a renowned expert in the field of rheumatology and immunology, was named the new chief of the Division of Rheumatology and Immunology at Duke University School of Medicine, Durham, N.C. Dr. Clowse, who serves as an associate professor of medicine in Duke’s Division of Rheumatology and Immunology…
In Memoriam: Robert W. Lightfoot Jr., MD
On Nov. 4, 2022, the world lost a learned professor, a dedicated doctor, an inquisitive scientist, an adept clinician and, above all, an epitome of Athena’s representation of Mentor in Homer’s Odyssey. Robert W. Lightfoot Jr., MD, had come a long way. Born in 1937, toward the end of the Great Depression, in Nashville, Tenn.,…
In Memoriam: Remembering Richard Brasington Jr., MD, FACP, MACR
On April 30, 2023, the world lost Richard Brasington Jr., MD, FACP, MACR, an illustrious clinical puzzle master who stopped at nothing to do right by his patients—and to ensure the next generation of rheumatologists would be properly trained. Dr. Brasington, a former associate editor of The Rheumatologist and emeritus professor of medicine at Washington…
ACR Image Competition 2023 Results, Part 3—People’s Choice Winner
For the 2023 Image Competition, the ACR sought images representing a diverse range of patients with idiopathic inflammatory myopathies (IIMs) or IIM mimics. Chronic Facial Ulcers in Anti-Melanoma-Differentiation-Associated Gene 5 (MDA-5) Antibody Amyopathic Dermatomyositis These images depict a 27-year-old patient who developed erythematous violaceous lesions over his upper chest, face and scalp over six months….
The 2023 ARP President’s Awards
SAN DIEGO—During ACR Convergence 2023 in November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist profiles the recipients of the ARP President’s Awards. The ARP president can choose to honor ACR/ARP members or teams performing outstanding…
3 AC&R Study Summaries: Prescribing Patterns, PMR & Glucocorticoids, & Infection Screening
A Shift in Prescribing Patterns Safety issues prompt discontinuation of tofacitinib By Stephanie Song, MD, & Joshua F. Baker, MD, MSCE Why was this study done? The ORAL Surveillance study highlighted risks of cardiac events, thromboembolism (VTE) and malignancy associated with use of Janus kinase inhibitors (JAKi). We sought to determine the impact of safety…
- « Previous Page
- 1
- …
- 43
- 44
- 45
- 46
- 47
- …
- 814
- Next Page »